Long intergenic non-protein coding RNA 892 (LINC00892)

Long intergenic non-protein coding RNA 892 (LINC00892) is a long non-coding RNA (lncRNA) predominantly expressed in immune cells, particularly activated T cells such as T follicular helper (TFH) cells, both in normal lymphatic tissues and in follicular lymphoma[1][3][4]. Its expression is strongly upregulated following T cell activation and is tightly correlated with immune markers such as CD40LG[1][3]. LINC00892 has been shown to inhibit cell proliferation, migration, and invasion, and to promote apoptosis in lung adenocarcinoma models, functioning as a tumor suppressor partly by modulating immune cell infiltration and epithelial-mesenchymal transition (EMT)[2]. Its restricted expression in memory/activated T cells, association with patient prognosis in cancer, and potential use as a tissue biomarker make LINC00892 a candidate molecular target for cancer diagnostics and possibly future immunotherapy, though there are no known direct drug interactions or clinical inhibitors currently identified[2][3][4].

Other names

LINC00892linc00892

As a potential therapeutic target, hypothetical mechanisms involve modulation of immune cell infiltration, regulation of EMT, and tumor suppression in cancer contexts. There are no approved drugs or precise mechanisms of action established for pharmacological targeting at present.